Klinghammer K - Search Results

1

Targeted treatment in a case series of AR+, HRAS/PIK3CA co-mutated salivary duct carcinoma.

Rieke DT, Schröder S, Schafhausen P, Blanc E, Zuljan E, von der Emde B, Beule D, Keller U, Keilholz U, Klinghammer K. Rieke DT, et al. Among authors: klinghammer k. Front Oncol. 2023 Jun 20;13:1107134. doi: 10.3389/fonc.2023.1107134. eCollection 2023. Front Oncol. 2023. PMID: 37427101 Free PMC article.

2

Association of epidermal growth factor receptor polymorphism, skin toxicity, and outcome in patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Klinghammer K, Knödler M, Schmittel A, Budach V, Keilholz U, Tinhofer I. Klinghammer K, et al. Clin Cancer Res. 2010 Jan 1;16(1):304-10. doi: 10.1158/1078-0432.CCR-09-1928. Epub 2009 Dec 22. Clin Cancer Res. 2010. PMID: 20028750

3

Expression of amphiregulin and EGFRvIII affect outcome of patients with squamous cell carcinoma of the head and neck receiving cetuximab-docetaxel treatment.

Tinhofer I, Klinghammer K, Weichert W, Knödler M, Stenzinger A, Gauler T, Budach V, Keilholz U. Tinhofer I, et al. Among authors: klinghammer k. Clin Cancer Res. 2011 Aug 1;17(15):5197-204. doi: 10.1158/1078-0432.CCR-10-3338. Epub 2011 Jun 8. Clin Cancer Res. 2011. PMID: 21653686 Clinical Trial.

4

PI3K/PTEN/AKT/mTOR polymorphisms: association with clinical outcome in patients with head and neck squamous cell carcinoma receiving cetuximab-docetaxel.

Pfisterer K, Fusi A, Klinghammer K, Knödler M, Nonnenmacher A, Keilholz U. Pfisterer K, et al. Among authors: klinghammer k. Head Neck. 2015 Apr;37(4):471-8. doi: 10.1002/hed.23604. Epub 2015 Feb 7. Head Neck. 2015. PMID: 24421178

5

A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option.

Klinghammer K, Raguse JD, Plath T, Albers AE, Joehrens K, Zakarneh A, Brzezicha B, Wulf-Goldenberg A, Keilholz U, Hoffmann J, Fichtner I. Klinghammer K, et al. Int J Cancer. 2015 Jun 15;136(12):2940-8. doi: 10.1002/ijc.29344. Epub 2014 Nov 26. Int J Cancer. 2015. PMID: 25404014

6

Methylation of RAD51B, XRCC3 and other homologous recombination genes is associated with expression of immune checkpoints and an inflammatory signature in squamous cell carcinoma of the head and neck, lung and cervix.

Rieke DT, Ochsenreither S, Klinghammer K, Seiwert TY, Klauschen F, Tinhofer I, Keilholz U. Rieke DT, et al. Among authors: klinghammer k. Oncotarget. 2016 Nov 15;7(46):75379-75393. doi: 10.18632/oncotarget.12211. Oncotarget. 2016. PMID: 27683114 Free PMC article.

7

Targeted Therapy of Head and Neck Cancer.

Rieke DT, Klinghammer K, Keilholz U. Rieke DT, et al. Among authors: klinghammer k. Oncol Res Treat. 2016;39(12):780-786. doi: 10.1159/000452432. Epub 2016 Nov 22. Oncol Res Treat. 2016. PMID: 27889751 Review.

8

Basal subtype is predictive for response to cetuximab treatment in patient-derived xenografts of squamous cell head and neck cancer.

Klinghammer K, Otto R, Raguse JD, Albers AE, Tinhofer I, Fichtner I, Leser U, Keilholz U, Hoffmann J. Klinghammer K, et al. Int J Cancer. 2017 Sep 15;141(6):1215-1221. doi: 10.1002/ijc.30808. Epub 2017 Jun 21. Int J Cancer. 2017. PMID: 28560858

9

Support of a molecular tumour board by an evidence-based decision management system for precision oncology.

Lamping M, Benary M, Leyvraz S, Messerschmidt C, Blanc E, Kessler T, Schütte M, Lenze D, Jöhrens K, Burock S, Klinghammer K, Ochsenreither S, Sers C, Schäfer R, Tinhofer I, Beule D, Klauschen F, Yaspo ML, Keilholz U, Rieke DT. Lamping M, et al. Among authors: klinghammer k. Eur J Cancer. 2020 Mar;127:41-51. doi: 10.1016/j.ejca.2019.12.017. Epub 2020 Jan 23. Eur J Cancer. 2020. PMID: 31982633

10

Distinct immune evasion in APOBEC-enriched, HPV-negative HNSCC.

Messerschmidt C, Obermayer B, Klinghammer K, Ochsenreither S, Treue D, Stenzinger A, Glimm H, Fröhling S, Kindler T, Brandts CH, Schulze-Osthoff K, Weichert W, Tinhofer I, Klauschen F, Keilholz U, Beule D, Rieke DT. Messerschmidt C, et al. Among authors: klinghammer k. Int J Cancer. 2020 Oct 15;147(8):2293-2302. doi: 10.1002/ijc.33123. Epub 2020 Jun 18. Int J Cancer. 2020. PMID: 32468570

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters